<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Contemporary series of patients with nasal cavity and paranasal sinus tumors</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Contemporary series of patients with nasal cavity and paranasal sinus tumors</h1>
<div class="graphic"><div class="figure"><div class="ttl">Contemporary series of patients with nasal cavity and paranasal sinus tumors</div><div class="cntnt"><table cellspacing="0"><colgroup span="8" width="12%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1">Site:</td> <td class="subtitle1"><span style="white-space: nowrap;">MSKCC<sup>[1]</sup></span></td> <td class="subtitle1">UCSF<sup>[2]</sup></td> <td class="subtitle1">MDACC<sup>[3]</sup></td> <td class="subtitle1">UF<sup>[4]</sup></td> <td class="subtitle1">Ghent <span style="white-space: nowrap;">University<sup>[5]</sup></span></td> <td class="subtitle1">UCLA and Geneva <span style="white-space: nowrap;">Switzerland<sup>[6]</sup></span></td> <td class="subtitle1"><span style="white-space: nowrap;">UFHPTI<sup>[7]</sup></span></td> </tr> <tr class="divider_bottom"> <td>Year</td> <td class="centered">2007</td> <td class="centered">2007</td> <td class="centered">2008</td> <td class="centered">2009</td> <td class="centered">2012</td> <td class="centered">2012</td> <td class="centered">2016</td> </tr> <tr class="divider_bottom"> <td>Number of patients</td> <td class="centered">85</td> <td class="centered">127</td> <td class="centered">68</td> <td class="centered">109</td> <td class="centered">130</td> <td class="centered">220</td> <td class="centered">84</td> </tr> <tr class="divider_bottom"> <td>Patients with nasal cavity tumors (%)</td> <td class="centered">28</td> <td class="centered">28</td> <td class="centered">100</td> <td class="centered">63</td> <td class="centered">24</td> <td class="centered">30</td> <td class="centered">80</td> </tr> <tr> <td class="divider_bottom" colspan="8"><strong>Stage (%)</strong></td> </tr> <tr> <td class="indent1">T1-T2</td> <td class="centered">12</td> <td class="centered">13</td> <td class="centered">60</td> <td class="centered">39</td> <td class="centered">30</td> <td class="centered">34</td> <td class="centered">6</td> </tr> <tr> <td class="indent1">T3-T4</td> <td class="centered">81</td> <td class="centered">87</td> <td class="centered">34</td> <td class="centered">61</td> <td class="centered">62</td> <td class="centered">65</td> <td class="centered">94</td> </tr> <tr> <td class="indent1">Tx</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">6</td> <td class="centered">–</td> <td class="centered">8</td> <td class="centered">–</td> <td class="centered">–</td> </tr> <tr> <td class="indent1">Node positive</td> <td class="centered">7</td> <td class="centered">9</td> <td class="centered">9</td> <td class="centered">10</td> <td class="centered">3</td> <td class="centered">2</td> <td class="centered">9</td> </tr> <tr class="divider_bottom"> <td class="indent1">Recurrent</td> <td class="centered">7</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">8</td> </tr> <tr> <td class="divider_bottom" colspan="8"><strong>Histology (%)</strong></td> </tr> <tr> <td class="indent1">Squamous cell</td> <td class="centered">49</td> <td class="centered">65</td> <td class="centered">66</td> <td class="centered">29</td> <td class="centered">18</td> <td class="centered">57</td> <td class="centered">26</td> </tr> <tr> <td class="indent1">Adenoid cystic</td> <td class="centered">13</td> <td class="centered">22</td> <td class="centered">18</td> <td class="centered">15</td> <td class="centered">4</td> <td class="centered">16</td> <td class="centered">17</td> </tr> <tr> <td class="indent1">Adenocarcinoma</td> <td class="centered">–</td> <td class="centered">13</td> <td class="centered">12</td> <td class="centered">8</td> <td class="centered">63</td> <td class="centered">11</td> <td class="centered">10</td> </tr> <tr> <td class="indent1">Sarcoma</td> <td class="centered">11</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> </tr> <tr> <td class="indent1">Sinonasal undifferentiated carcinoma</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">4</td> <td class="centered">13</td> <td class="centered">6</td> <td class="centered">14</td> <td class="centered">8</td> </tr> <tr> <td class="indent1">Olfactory neuroblastoma</td> <td class="centered">8</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">20</td> <td class="centered">8</td> <td class="centered">–</td> <td class="centered">27</td> </tr> <tr class="divider_bottom"> <td class="indent1">Other</td> <td class="centered">20</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">15</td> <td class="centered">1</td> <td class="centered">2</td> <td class="centered">12</td> </tr> <tr> <td class="divider_bottom" colspan="8"><strong>Treatment (%)</strong></td> </tr> <tr> <td class="indent1">RT alone</td> <td class="centered">–</td> <td class="centered">16</td> <td class="centered">47</td> <td class="centered">52</td> <td class="centered">22</td> <td class="centered">28</td> <td class="centered">13</td> </tr> <tr> <td class="indent1">Preoperative RT</td> <td class="centered">–</td> <td class="centered">7</td> <td class="centered">4</td> <td class="centered">7</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> </tr> <tr> <td class="indent1">Postoperative RT</td> <td class="centered">100</td> <td class="centered">77</td> <td class="centered">49</td> <td class="centered">41</td> <td class="centered">78</td> <td class="centered">52</td> <td class="centered">87</td> </tr> <tr class="divider_bottom"> <td class="indent1">Surgery without RT</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">20</td> <td class="centered">–</td> </tr> <tr class="divider_bottom"> <td>Median RT dose</td> <td class="centered">63 Gy</td> <td class="centered">RT alone, 66 Gy;<br/> Post-op RT, 63 Gy</td> <td class="centered">RT alone, 65 Gy;<br/> Post-op RT, 58 Gy</td> <td class="centered">RT alone, 70 Gy;<br/> Post-op RT, 64.8 Gy</td> <td class="centered">70 Gy</td> <td class="centered"> </td> <td class="centered">73.8 Gy (RBE) protons</td> </tr> <tr class="divider_bottom"> <td>Five-year local control (%)</td> <td class="centered">62</td> <td class="centered">62</td> <td class="centered">86</td> <td class="centered">63</td> <td class="centered">59</td> <td class="centered">57</td> <td class="centered">83 (three years)</td> </tr> <tr class="divider_bottom"> <td>Five-year regional control (%)</td> <td class="centered">87</td> <td class="centered">–</td> <td class="centered">92</td> <td class="centered">91</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">94 (three years)</td> </tr> <tr class="divider_bottom"> <td>Five-year disease-free survival (%)</td> <td class="centered">55</td> <td class="centered">54</td> <td class="centered">86</td> <td class="centered">–</td> <td class="centered">43</td> <td class="centered">–</td> <td class="centered">73 (three years)</td> </tr> <tr class="divider_bottom"> <td>Five-year overall survival (%)</td> <td class="centered">67</td> <td class="centered">52</td> <td class="centered">82</td> <td class="centered">55</td> <td class="centered">64</td> <td class="centered">63</td> <td class="centered">63 (three years)</td> </tr> <tr> <td>Notes</td> <td>Worse outcomes for squamous cell carcinoma, cribriform plate or orbit invasion, and positive nodes.</td> <td>16% of postoperative RT patients had gross residual disease; 15% of all patients received chemotherapy. GTR improved local control compared with STR (65 versus 44%).</td> <td>Worse outcomes for nonsquamous cell histologies and T3-4 tumors.</td> <td>19% distant metastasis rate; 30% severe complications rate. Outcomes significantly improved with post-op RT compared with RT alone.</td> <td>Only two regional failures. Intensity-modulated RT improved outcomes.</td> <td>Only 3% of patients failed in nodes. Worse prognosis in nonnasal cavity primaries, squamous cell, and undifferentiated histologies, as well as advanced T stage.</td> <td>90% local control in patients without gross disease. 24% grade 3 or worse toxicity.</td> </tr> </tbody></table></div><div class="graphic_footnotes">MSKCC: Memorial Sloan-Kettering Cancer Center (New York, NY); MDACC: MD Anderson Cancer Center (Houston, TX); UCSF: University of California San Francisco (San Francisco, CA); UF: University of Florida (Gainesville, FL); UCLA: University of California Los Angeles (Los Angeles, CA); UFHPTI: University of Florida Health Proton Therapy Institute (Jacksonville, FL); RT: radiotherapy; Post-op: postoperative; RBE: relative biological effectiveness; GTR: gross total resection; STR: subtotal resection.</div><div class="graphic_reference">References:

<ol>
<li>Hoppe BS, Stegman LD, Zelefsky MJ, et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience. Int J Radiat Oncol Biol Phys 2007; 67:691.</li>
<li>Chen AM, Daly ME, Bucci MK, et al. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys 2007; 69:141.</li>
<li>Allen MW, Schwartz DL, Rana V, et al. Long-term radiotherapy outcomes for nasal cavity and septal cancers. Int J Radiat Oncol Biol Phys 2008; 71:401.</li>
<li>Mendenhall WM, Amdur RJ, Morris CG, et al. Carcinoma of the nasal cavity and paranasal sinuses. Laryngoscope 2009; 119:899.</li>
<li>Duprez F, Madani I, Morbee L, et al. IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival. Int J Radiat Oncol Biol Phys 2012; 83:252.</li>
<li>Dulguerov P, Jacobsen MS, Allal AS, et al. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001; 92:3012.</li>
<li>Dagan R, Bryant C, Li Z, et al. Outcomes of sinonasal cancer treated with proton therapy. Int J Radiat Oncol Biol Phys 2016; 95:377.</li>
</ol></div><div id="graphicVersion">Graphic 97228 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
